<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=US-ASCII">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>Extropians: RNAi</title>
<meta name="Author" content="Spudboy100@aol.com (Spudboy100@aol.com)">
<meta name="Subject" content="RNAi">
<meta name="Date" content="2003-03-08">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>RNAi</h1>
<!-- received="Sat Mar  8 01:14:59 2003" -->
<!-- isoreceived="20030308081459" -->
<!-- sent="Sat, 8 Mar 2003 03:14:47 EST" -->
<!-- isosent="20030308081447" -->
<!-- name="Spudboy100@aol.com" -->
<!-- email="Spudboy100@aol.com" -->
<!-- subject="RNAi" -->
<!-- id="1c7.655b84c.2b9b0077@aol.com" -->
<!-- charset="US-ASCII" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> <a href="mailto:Spudboy100@aol.com?Subject=Re:%20RNAi"><em>Spudboy100@aol.com</em></a><br>
<strong>Date:</strong> Sat Mar 08 2003 - 01:14:47 MST
</p>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="3994.html">John Grigg: "The Alcor Standby Training Session at Creekside/Ventureville"</a>
<ul>
<li><strong>Previous message:</strong> <a href="3992.html">Hal Finney: "Re: Do patents really foster innovation?"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#3993">[ date ]</a>
<a href="index.html#3993">[ thread ]</a>
<a href="subject.html#3993">[ subject ]</a>
<a href="author.html#3993">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
<a href="http://businessweek.com/magazine/content/03_10/b3823094.htm">http://businessweek.com/magazine/content/03_10/b3823094.htm</a>
<br>
<p>&lt;&lt;...Why shell out so much for a troubled drug developer? Because Ribozyme 
<br>
has refocused its research on an experimental cell-based therapy that 
<br>
scientists call one of the biggest biological breakthroughs of the last two 
<br>
decades. The mechanism it seeks to exploit may amount to an off-switch for 
<br>
some disease processes in human cells. Scientists activate the switch by 
<br>
introducing small double strands of RNA, the same messenger molecules that 
<br>
translate DNA code into proteins. Knowledge of this process, called RNA 
<br>
interference (RNAi), is so preliminary that, until two years ago, the 
<br>
technique worked only in plants, worms, and fungi.
<br>
<p>Since then, RNAi has swept science faster than a cold virus. Pharmaceutical 
<br>
companies and labs worldwide are using it as a tool to help find better 
<br>
targets for drugs to attack. Venture capitalists are pouring in cash, in the 
<br>
hope they have discovered a magic bullet for treating diseases from hepatitis 
<br>
C to cancer to AIDS. New biotech companies are scrambling to develop drugs 
<br>
based on the technique, and some older ones such as Ribozyme are shifting to 
<br>
embrace it. &quot;It's revolutionizing science,&quot; says Gary Ruvkun, a professor of 
<br>
genetics at Harvard Medical School...
<br>
&nbsp;&nbsp;&nbsp;&nbsp;
<br>
&nbsp;&nbsp;&nbsp;&nbsp;
<br>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="3994.html">John Grigg: "The Alcor Standby Training Session at Creekside/Ventureville"</a>
<li><strong>Previous message:</strong> <a href="3992.html">Hal Finney: "Re: Do patents really foster innovation?"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#3993">[ date ]</a>
<a href="index.html#3993">[ thread ]</a>
<a href="subject.html#3993">[ subject ]</a>
<a href="author.html#3993">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Sat Mar 08 2003 - 01:20:25 MST
</em></small></p>
</body>
</html>
